Reports
Reports
Sale
The global dermatology diagnostic devices market was valued at USD 9.6 billion in 2023, driven by the increasing prevalence of skin diseases across the globe. The market is expected to grow at a CAGR of 12.24% during the forecast period of 2024-2032, with the values likely to reach USD 26.7 billion by 2032.
Dermatology diagnostic devices help in the diagnosis and monitoring of various skin conditions. 3D imaging systems help to capture detailed, three-dimensional images of the skin whereas dermatoscopes are widely used to get magnified images of skin lesions. The market is experiencing a rising integration of artificial intelligence into dermatology diagnostic devices to achieve optimal diagnostic accuracy. The increasing burden of skin disorders, including skin cancer, psoriasis, and dermatitis, is a major factor propelling the market demand for advanced diagnostic solutions. Moreover, the expansion of specialized dermatology clinics and the growing investment in healthcare infrastructure are expected to support market growth in the coming years.
Increasing Prevalence of Skin Diseases Drives Market Growth
According to the World Health Organisation (WHO), 1.8 billion individuals are estimated to be affected by skin conditions at any point in time. Skin-related neglected tropical diseases (skin NTDs) are reported to form around 10% of skin diseases. Further, it is reported that melanoma (a type of skin cancer) kills roughly 20 Americans every day, with around 8,290 deaths projected to be caused by this skin cancer in 2024. Thus, the rising prevalence of skin disorders is anticipated to drive the demand for dermatology diagnostic devices.
Use of Artificial Intelligence Set to Boost Dermatology Diagnostic Devices Market Demand
In April 2024, a Stanford Medicine-led meta-analysis findings indicated that artificial intelligence (AI)-powered tools can help in improving skin cancer diagnostic accuracy of healthcare practitioners, revealing the potential of AI in imaging-heavy specialties such as dermatology. In this study, the researchers compared the diagnostic performance of physicians with and without AI assistance. It was reported that the practitioners working with AI accurately diagnosed 81.1% and 86.1% of skin cancer cases and cancer-like skin conditions, respectively. The development of such AI-driven skin cancer diagnostic tools is likely to bolster the market demand in the forecast period.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Advancements in Imaging Technologies
One of the major market trends is the rising advancements in high-resolution imaging technologies. The introduction of multispectral imaging and 3D imaging are improving the capabilities of diagnostic devices for dermatology applications and are expected to fuel market growth.
Growth of Aesthetic Dermatology
There is a growing demand for cosmetic dermatology procedures such as laser treatments, chemical peels, and microneedling. The rising popularity of aesthetic dermatology is propelling the adoption of diagnostic solutions to examine skin health and monitor treatment outcomes, which is likely to boost the dermatology diagnostic devices market value.
Innovation in Non-Invasive Diagnostics
The rising patient preference towards non-invasive and minimally invasive diagnostic techniques is a major market trend that is fuelling the demand for advanced dermatology diagnostic devices. For instance, techniques such as optical coherence tomography (OCT) and reflectance confocal microscopy (RCM) help in offering detailed skin imaging without the need for surgical biopsies.
Surge in Strategic Collaborations and Partnerships
The market is witnessing a rise in strategic partnerships between device manufacturers, healthcare providers, and research institutions in order to stimulate innovation and development of advanced diagnostic tools. Several market players are collaborating with tech companies to develop diagnostic devices with enhanced capabilities.
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Product is Anticipated to Witness Substantial Growth
The market segmentation by product includes imaging devices, dermatoscopes, microscopes, and others. The imaging devices segment holds a significant market share, owing to the increasing prevalence of skin disorders and rising innovations in imaging tools. Advanced imaging technologies, such as 3D imaging systems and digital ultrasound imaging devices, are increasingly used in various dermatological assessments and thus are widely adopted in dermatology clinics and hospitals.
On the basis of region, North America covers the largest market share which can be attributed to the rising burden of skin cancer and other skin conditions in the region. The presence of a high number of dermatology clinics and hospitals also makes diagnostic services more accessible to the population. Moreover, the rapid adoption of advanced dermatology diagnostic solutions and a substantial R&D investment in the healthcare sector are some of the factors propelling the market growth.
Europe also holds a significant dermatology diagnostic devices market value, driven by the implementation of favorable regulations that stimulate innovation and the accelerated entry of innovative diagnostic tools to the market. Additionally, increasing cases of skin diseases such as melanoma and eczema are also contributing to the growing market demand for dermatology services and devices in European countries.
The key features of the market report comprise the patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Carl Zeiss Meditec AG
Multinational medical technology, Carl Zeiss Meditec AG is a Germany-based subsidiary of Carl Zeiss AG. The company is known for its advanced imaging solutions, including high-resolution microscopes and optical coherence tomography (OCT) devices.
Caliber I.D. Inc
Caliber Imaging & Diagnostics Inc., a medical device company, develops and markets point-of-care cellular imaging systems designed to diagnose skin cancer. The company is widely recognized for its clinical imaging solutions that help in the visualization of tissue at the cellular level. Caliber I.D. boasts a robust portfolio including VivaScope, VivaNet, and VivaScan.
Michelson Diagnostic Devices Limited
Based in Bromley, United Kingdom, Michelson Diagnostic Devices Limited specializes in the development of multi-beam optical coherence tomography-based products that can enable the imaging of living tissue microstructure at less than 10 µm resolution. One of its leading products is VivoSight Dx, an innovative optical coherence tomography (OCT) system.
Other key players in the market include Bomtech Electronics Co., Canfield Imaging Systems, ILLUCO Corporation Ltd., Nikon Corporation, DermoScan GmbH, DermLite, LLC., and Leica Microsystems GmbH.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Dermatology Diagnostic Devices Market Overview
3.1 Global Dermatology Diagnostic Devices Market Historical Value (2017-2023)
3.2 Global Dermatology Diagnostic Devices Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Dermatology Diagnostic Devices Market Landscape*
5.1 Global Dermatology Diagnostic Devices Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Dermatology Diagnostic Devices Market: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Application
6 Global Dermatology Diagnostic Devices Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Dermatology Diagnostic Devices Market Segmentation (2017-2032)
7.1 Global Dermatology Diagnostic Devices Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Imaging Devices
7.1.3 Dermatoscopes
7.1.4 Microscope
7.1.5 Others
7.2 Global Dermatology Diagnostic Devices Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Skin cancer
7.2.3 Psoriasis
7.2.4 Dermatitis
7.2.5 Hair & Scalp Disorders
7.2.6 Acne
7.2.7 Others
7.3 Global Dermatology Diagnostic Devices Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Dermatology Centers
7.3.3 Hospitals
7.3.4 Others
7.4 Global Dermatology Diagnostic Devices Market (2017-2032) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Dermatology Diagnostic Devices Market (2017-2032)
8.1 North America Dermatology Diagnostic Devices Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Imaging Devices
8.1.3 Dermatoscopes
8.1.4 Microscope
8.1.5 Others
8.2 North America Dermatology Diagnostic Devices Market (2017-2032) By Application
8.2.1 Market Overview
8.2.2 Skin cancer
8.2.3 Psoriasis
8.2.4 Dermatitis
8.2.5 Hair & Scalp Disorders
8.2.6 Acne
8.2.7 Others
8.3 North America Dermatology Diagnostic Devices Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Dermatology Centers
8.3.3 Hospitals
8.3.4 Others
8.4 North America Dermatology Diagnostic Devices Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Dermatology Diagnostic Devices Market (2017-2032)
9.1 Europe Dermatology Diagnostic Devices Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Imaging Devices
9.1.3 Dermatoscopes
9.1.4 Microscope
9.1.5 Others
9.2 Europe Dermatology Diagnostic Devices Market (2017-2032) By Application
9.2.1 Market Overview
9.2.2 Skin cancer
9.2.3 Psoriasis
9.2.4 Dermatitis
9.2.5 Hair & Scalp Disorders
9.2.6 Acne
9.2.7 Other
9.3 Europe Dermatology Diagnostic Devices Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Dermatology Centers
9.3.3 Hospitals
9.3.4 Others
9.4 Europe Dermatology Diagnostic Devices Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Dermatology Diagnostic Devices Market (2017-2032)
10.1 Asia Pacific Dermatology Diagnostic Devices Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Imaging Devices
10.1.3 Dermatoscopes
10.1.4 Microscope
10.1.5 Others
10.2 Asia Pacific Dermatology Diagnostic Devices Market (2017-2032) By Application
10.2.1 Market Overview
10.2.2 Skin cancer
10.2.3 Psoriasis
10.2.4 Dermatitis
10.2.5 Hair & Scalp Disorders
10.2.6 Acne
10.2.7 Other
10.3 Asia Pacific Dermatology Diagnostic Devices Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Dermatology Centers
10.3.3 Hospitals
10.3.4 Others
10.4 Asia Pacific Dermatology Diagnostic Devices Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Dermatology Diagnostic Devices Market (2017-2032)
11.1 Latin America Dermatology Diagnostic Devices Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Imaging Devices
11.1.3 Dermatoscopes
11.1.4 Microscope
11.1.5 Others
11.2 Latin America Dermatology Diagnostic Devices Market (2017-2032) By Application
11.2.1 Market Overview
11.2.2 Skin cancer
11.2.3 Psoriasis
11.2.4 Dermatitis
11.2.5 Hair & Scalp Disorders
11.2.6 Acne
11.2.7 Other
11.3 Latin America Dermatology Diagnostic Devices Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Dermatology Centers
11.3.3 Hospitals
11.3.4 Others
11.4 Latin America Dermatology Diagnostic Devices Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Dermatology Diagnostic Devices Market (2017-2032)
12.1 Middle East and Africa Dermatology Diagnostic Devices Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Imaging Devices
12.1.3 Dermatoscopes
12.1.4 Microscope
12.1.5 Others
12.2 Middle East and Africa Dermatology Diagnostic Devices Market (2017-2032) By Application
12.2.1 Market Overview
12.2.2 Skin cancer
12.2.3 Psoriasis
12.2.4 Dermatitis
12.2.5 Hair & Scalp Disorders
12.2.6 Acne
12.2.7 Other
12.3 Middle East and Africa Dermatology Diagnostic Devices Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Dermatology Centers
12.3.3 Hospitals
12.3.4 Others
12.4 Middle East and Africa Dermatology Diagnostic Devices Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Grants Analysis
15.1 Analysis by Year
15.2 Analysis by Amount Awarded
15.3 Analysis by Issuing Authority
15.4 Analysis by Grant Application
15.5 Analysis by Funding Institute
15.6 Analysis by NIH Departments
15.7 Analysis by Recipient Organization
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (Top 5 Companies)
18.1.1 Market Share Analysis: Global
18.1.2 Market Share Analysis: North America
18.1.3 Market Share Analysis: Europe
18.1.4 Market Share Analysis: Asia Pacific
18.1.5 Market Share Analysis: Others
18.2 Carl Zeiss Meditec AG
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Development
18.2.5 Certifications
18.3 Caliber I.D. Inc
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Development
18.3.5 Certifications
18.4 Michelson Diagnostic Devices Limited
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Development
18.4.5 Certifications
18.5 Bomtech Electronics Co.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Development
18.5.5 Certifications
18.6 Canfield Scientific, Inc.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Development
18.6.5 Certifications
18.7 Illuco Corporation Ltd.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News and Development
18.7.5 Certifications
18.8 Nikon Corporation
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News and Development
18.8.5 Certifications
18.9 DermoScan GmbH
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Company News and Development
18.9.5 Certifications
18.10 Leica Microsystems GmbH
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News and Development
18.10.5 Certifications
18.11 DermLite, LLC.
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Company News and Development
18.11.5 Certifications
19 Dermatology Diagnostic Devices Market – Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.